Status:
COMPLETED
Goal2Quit + NRT Sampling
Lead Sponsor:
Medical University of South Carolina
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Cigarette Smoking
Smoking Cessation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this work is to develop, systematically evaluate, and clinically test an integrated cessation intervention comprised of a depression-specific Behavioral Activation (BA) for cessation mobil...
Eligibility Criteria
Inclusion
- Current elevated depressive symptoms defined as a score of \> 10 (at least mild depression) on the Patient Health Questionnaire-8 (PHQ-8)
- Current smoking, defined as smoking 10+ cigarettes/day, for 25+ days out of the last 30, for the last 6+ months
- Ownership of an Android or iOS smartphone
- Age 18+
- Possess a valid e-mail address that is checked daily to access follow-up assessments
- English fluency
Exclusion
- \- Contraindications for NRT (pregnancy/intention to become pregnant/breastfeeding, recent cardiovascular trauma/uncontrolled hypertension) - Severe visual impairment, which may limit ability to utilize an app
Key Trial Info
Start Date :
June 22 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 18 2022
Estimated Enrollment :
164 Patients enrolled
Trial Details
Trial ID
NCT03837379
Start Date
June 22 2020
End Date
May 18 2022
Last Update
May 17 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of South Carolina
Charleston, South Carolina, United States, 29425